Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Mayer

Showing results (591-600 of 703) with videos related to

Pageof 71
Sort By:
Breast Cancer Research and Treatment|September 25, 2013
Personalized medicine in breast cancer: tamoxifen, endoxifen, and CYP2D6 in clinical practiceKathryn J Ruddy, Stephen D Desantis, Rebecca S Gelman, et al.
Breast Cancer Research and Treatment|May 7, 2013
A phase II study of bevacizumab in combination with vinorelbine and trastuzumab in HER2-positive metastatic breast cancerN U Lin, D S Seah, R Gelman, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|April 11, 2022
Magnetic resonance imaging detects improvements of pulmonary and paranasal sinus abnormalities in response to elexacaftor/tezacaftor/ivacaftor therapy in adults with cystic fibrosisLena Wucherpfennig, Simon M F Triphan, Sabine Wege, et al.
Cancer Chemotherapy and Pharmacology|February 15, 2021
Phase I study of JAK1/2 inhibitor ruxolitinib with weekly paclitaxel for the treatment of HER2-negative metastatic breast cancerFilipa Lynce, James T Williams, Meredith M Regan, et al.
Disease Models & Mechanisms|July 12, 2018
Fetal articular cartilage regeneration versus adult fibrocartilaginous repair: secretome proteomics unravels molecular mechanisms in an ovine modelIris Ribitsch, Rupert L Mayer, Monika Egerbacher, et al.
NPJ Breast Cancer|November 13, 2025
Evolving incidence patterns for locally advanced operable breast cancer by receptor status: SEER 2010-2021Alexandra Thomas, Anthony Rhoads, Erica L Mayer, et al.
Molecular & Cellular Proteomics : MCP|December 3, 2017
Proteomics and metabolomics identify molecular mechanisms of aging potentially predisposing for chronic lymphocytic leukemiaRupert L Mayer, Josef D Schwarzmeier, Marlene C Gerner, et al.
Diabetes Care|June 21, 2023
Influence of Gestational Diabetes Mellitus on Diabetes Risk and Glycemic Control in a Retrospective Population-Based CohortKatharine J McCarthy, Shelley H Liu, Mary Huynh, et al.
Scientific Reports|December 7, 2016
SLC2A8 (GLUT8) is a mammalian trehalose transporter required for trehalose-induced autophagyAllyson L Mayer, Cassandra B Higgins, Monique R Heitmeier, et al.
Gastroenterology|September 29, 1999
Efficacy and safety of retreatment with anti-tumor necrosis factor antibody (infliximab) to maintain remission in Crohn's diseaseP Rutgeerts, G D'Haens, S Targan, et al.
Pageof 71

Showing results (591-600 of 703) with videos related to

Sort By:
Pageof 71
Breast Cancer Research and Treatment|September 25, 2013
Personalized medicine in breast cancer: tamoxifen, endoxifen, and CYP2D6 in clinical practiceKathryn J Ruddy, Stephen D Desantis, Rebecca S Gelman, et al.
Breast Cancer Research and Treatment|May 7, 2013
A phase II study of bevacizumab in combination with vinorelbine and trastuzumab in HER2-positive metastatic breast cancerN U Lin, D S Seah, R Gelman, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|April 11, 2022
Magnetic resonance imaging detects improvements of pulmonary and paranasal sinus abnormalities in response to elexacaftor/tezacaftor/ivacaftor therapy in adults with cystic fibrosisLena Wucherpfennig, Simon M F Triphan, Sabine Wege, et al.
Cancer Chemotherapy and Pharmacology|February 15, 2021
Phase I study of JAK1/2 inhibitor ruxolitinib with weekly paclitaxel for the treatment of HER2-negative metastatic breast cancerFilipa Lynce, James T Williams, Meredith M Regan, et al.
Disease Models & Mechanisms|July 12, 2018
Fetal articular cartilage regeneration versus adult fibrocartilaginous repair: secretome proteomics unravels molecular mechanisms in an ovine modelIris Ribitsch, Rupert L Mayer, Monika Egerbacher, et al.
NPJ Breast Cancer|November 13, 2025
Evolving incidence patterns for locally advanced operable breast cancer by receptor status: SEER 2010-2021Alexandra Thomas, Anthony Rhoads, Erica L Mayer, et al.
Molecular & Cellular Proteomics : MCP|December 3, 2017
Proteomics and metabolomics identify molecular mechanisms of aging potentially predisposing for chronic lymphocytic leukemiaRupert L Mayer, Josef D Schwarzmeier, Marlene C Gerner, et al.
Diabetes Care|June 21, 2023
Influence of Gestational Diabetes Mellitus on Diabetes Risk and Glycemic Control in a Retrospective Population-Based CohortKatharine J McCarthy, Shelley H Liu, Mary Huynh, et al.
Scientific Reports|December 7, 2016
SLC2A8 (GLUT8) is a mammalian trehalose transporter required for trehalose-induced autophagyAllyson L Mayer, Cassandra B Higgins, Monique R Heitmeier, et al.
Gastroenterology|September 29, 1999
Efficacy and safety of retreatment with anti-tumor necrosis factor antibody (infliximab) to maintain remission in Crohn's diseaseP Rutgeerts, G D'Haens, S Targan, et al.
Pageof 71